Filing Details
- Accession Number:
- 0000878526-21-000051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-01 17:48:30
- Reporting Period:
- 2021-05-27
- Accepted Time:
- 2021-06-01 17:48:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 878526 | Natus Medical Inc | NTUS | Electromedical & Electrotherapeutic Apparatus (3845) | 770154833 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221306 | Christopher Chune Dong Chung | C/O Natus Medical Incorporated 6701 Koll Center Parkway, Suite 120 Pleasanton CA 94566 | Vp Of Medical Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Disposition | 2021-05-27 | 10,467 | $27.10 | 53,234 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value Per Share | Disposition | 2021-05-28 | 808 | $26.90 | 52,426 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value Per Share | Disposition | 2021-06-01 | 12,500 | $27.55 | 39,926 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $27.02 to $27.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $27.54 to $27.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
